HOHuseyin Dogus Okan

Huseyin Dogus Okan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Huseyin Dogus Okan has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence and characteristics of persistent symptoms following hospitalization for COVID-19: a cross-sectional follow-up study

    by Huseyin Dogus Okan, Gulsum Kaya

    Although coronavirus disease 2019 (COVID-19) primarily presents as an acute respiratory infection, many patients continue to experience symptoms after the acute phase of the disease. Early persistent symptoms during the post-acute recovery period may adversely affect functional recovery and quality of life. This study aimed to evaluate persistent symptoms in hospitalized COVID-19 patients following completion of the quarantine period. This retrospective longitudinal follow-up study evaluated hospitalized COVID-19 patients after completion of quarantine/isolation to determine the prevalence and characteristics of persistent symptoms. Descriptive statistics and chi-square or Fisher's exact tests were used, with p < 0.05 considered statistically significant. A total of 180 patients were included, with a mean age of 50.63 ± 16.90 years, and 52.8% were female. At initial presentation, the most common symptoms were weakness (53.9%), diffuse body/muscle/joint pain (48.9%), cough (48.3%), fever (41.1%), loss of taste and smell (30.0%), headache (28.3%), and dyspnea (24.4%). Persistent symptoms after the quarantine period were observed in 64.9% of patients. The most common persistent symptoms were cough (28.9%), weakness (28.9%), diffuse body/muscle/joint pain (20.0%), loss of taste and smell (13.3%), dyspnea (12.8%), fatigue/exhaustion (12.8%), and headache (11.1%). Significant reductions were observed in several symptoms after the acute phase, including fever, sore throat, headache, diarrhea, and abdominal pain (p < 0.05). Persistent symptoms were frequently observed during the early post-acute recovery period in hospitalized COVID-19 patients. Respiratory complaints, fatigue, weakness, and musculoskeletal symptoms remained common after the acute infectious period. These findings emphasize the importance of post-discharge follow-up and supportive care strategies in patients recovering from COVID-19. Not applicable.

  • New Prognostic Parameter of West Nile Virus: Platelet Distribution Width

    by Ahmed Cihad Genc, Oğuz Karabay, Ertuğrul Güçlü, Aylin Çalıca Utku, Aslı Vatan, Nazan Tuna, Gökçen Budak, Adem Şimşek, Cem Uzun, Sevgi Alan, et al.

    Background: West Nile virus (WNV) infection is a viral disease caused by arboviruses. It can cause epidemics of febrile diseases and meningoencephalitis, especially at the end of the summer season. In this study, we aimed to determine the risk factors of WNV encephalitis with a case–control study of the patients followed in our clinic. Materials and Methods: Among the patients who applied to our hospital with sudden onset fever, headache, myalgia, nausea, vomiting, maculopapular rash, viral meningitis, or encephalitis findings in late summer and early autumn, those diagnosed with positive WNV PCR and antibody tests were defined as WNV cases. In the same date range, patients with clinically compatible but negative serological and PCR tests for WNV in our hospital were considered as the control group. Results: WNV infection was diagnosed in 26 of 48 patients who were examined with a preliminary diagnosis of WNV infection, and the other 22 patients were considered as the control group. A statistically significant difference was found between the two groups in C-reactive protein, procalcitonin, 1-h erythrocyte sedimentation rate, alkaline phosphatase, platelet, and platelet distribution width (PDW). PDW >17.85% indicated WNV infection with 82% sensitivity and 91% specificity. PDW percentage >17.85 increased the risk of WNV infection by 6.1 times. The power of the study was calculated as 83%. Conclusion: The most common findings in WNV cases were fever and confusion. WNV infection should be considered in the differential diagnosis in patients with fever and confusion in September and October in settlements on the migration route of birds. The percentage of PDW in whole blood examination can guide the differential diagnosis of WNV cases.


  • Open Access

    Comparison of patients using lamivudine, entecavir, and tenofovir according to liver fibrosis markers fibrosis-4 and aspartate aminotransferase-to-platelet ratio index scores

    by Huseyin Dogus Okan, Oguz Karabay, Ertugrul Guclu, Mustafa Baran Inci, Aziz Ogutlu

    OBJECTIVES: It was intended to assess the efficacy of lamivudine, entecavir, and tenofovir regimens in the management of chronic hepatitis B (CHB) guided by Fibrosis-4 (FIB-4) and aspartate aminotransferase-to-platelet ratio index (APRI) scores. MATERIALS AND METHODS: Our study was conducted on patients who applied to the hepatitis outpatient clinic between 2008 and 2015 retrospectively. Lamivudine, entecavir, and tenofovir regimens used in the practice of CHB cases were compared by measuring noninvasive FIB tests. RESULTS: Entirely 199 patients involved in the research were evaluated in three treatment arms; 48 used lamivudine, 46 used entecavir, and 105 used tenofovir. Similar statistical characteristics were observed between research arms regarding age, gender, and alanine aminotransferase normalization by years (P > 0.05). Totally 5 (13.5%) of patients developed Hepatitis B e antigen (HBeAg) seroconversion among 36 HBeAg positivity, and similar statistical features were seen by comparing the groups (P > 0.05). In the entecavir and tenofovir arms, a significant decrease was seen in FIB-4, and APRI index values in the 1st year of treatment (P < 0.001). At the graph curve, a plateau was observed in the APRI test after the 1st year, and a plateau was observed in the FIB-4 test after the 2nd year. CONCLUSION: Consistent with the study outcome, when we consider FIB regression, tenofovir and entecavir regimens were found more effective than lamivudine. In addition, entecavir was more effective than the other two drugs after the 1st year.


  • Open Access

    Predictive Factors For Severe And Critical Coronavirus Disease-19 In Young Adults

    by Aslı VATAN, Hüseyin Doğuş OKAN, Aylin Çalica Utku, Gökcen Gürkök Budak, Ertuğrul GÜÇLÜ, Elif Köse, Aziz Öğütlü, Oğuz Karabay

    Predictive Factors For Severe And Critical Coronavirus Disease-19 In Young Adults Abstract Objective: Advanced age is associated with a poor prognosis in Coronavirus disease-2019 (COVID-19). The present study was conducted with the aim of investigating the predictive factors for disease severity in young adults. Materials and Methods: A total of 399 patients with COVID-19 aged under 60 who had been hospitalized at our hospital were retrospectively evaluated. Patients were stratified into mild, moderate, severe, and critical groups according to their respiratory rate, SpO2, and PaO2/FiO2 levels. The relationship between the signs and symptoms on hospital admission and the disease severity was evaluated. Results: The patients were classified as mild (n:112), moderate (n:192), severe and critical (n:95) according to disease severity. The mean age was 44. 43 of 399 patients were followed in the intensive care unit and 17 patients died. According to the binary logistic regression analysis, advanced age, hypertension, dyspnea on admission, elevated CRP, decreased lymphocyte and eosinophil count, presence of multiple bilateral ground glass appearance and consolidation were independently predicted the severity of disease. Conclusion: The signs and symptoms should be evaluated in detail also in young patients with COVID-19 and if risk factors are detected, they should be monitored more closely for predicting a poor prognosis.


  • Open Access

    Effect of COVID-19 on platelet count and its indices

    by Ertuğrul Güçlü, Havva Kocayiğit, Hüseyin Doğuş Okan, Unal Erkorkmaz, Yusuf Yürümez, Selcuk Yaylacı, Mehmet Koroglu, Cem Uzun, Oğuz Karabay

    SUMMARY BACKGROUND Easily accessible, inexpensive, and widely used laboratory tests that demonstrate the severity of COVID-19 are important. Therefore, in this study, we aimed to investigate the relationship between mortality in COVID-19 and platelet count, Mean Platelet Volume (MPV), and platelet distribution width. METHODS In total, 215 COVID-19 patients were included in this study. The patients were divided into two groups. Patients with room air oxygen saturation < 90% were considered as severe COVID-19, and patients with ≥90% were considered moderate COVID-19. Patient medical records and the electronic patient data monitoring system were examined retrospectively. Analyses were performed using the SPSS statistical software. A p-value <0.05 was considered significant. RESULTS The patients’ mean age was 64,32 ± 16,07 years. According to oxygen saturation, 81 patients had moderate and 134 had severe COVID-19. Our findings revealed that oxygen saturation at admission and the MPV difference between the first and third days of hospitalization were significant parameters in COVID-19 patients for predicting mortality. While mortality was 8.4 times higher in patients who had oxygen saturation under 90 % at hospital admission, 1 unit increase in MPV increased mortality 1.76 times. CONCLUSION In addition to the lung capacity of patients, the mean platelet volume may be used as an auxiliary test in predicting the mortality in COVID-19 patients.


  • Travel Related Fever and Rash: Two Cases of Dengue Fever

    by Oğuz Karabay, Ertuğrul GÜÇLÜ, Adem Şi̇mşek, Hüseyin Doğuş OKAN, Aziz Öğütlü, Yasemin Coşgun, Dilek Menemenli̇oğlu

    The frequency of travel-related infections in the world has increased due to the easily and widespread use of travel facilities in the 21st century. Vector-borne diseases are an important part of infectious diseases. Dengue fever is one of the travel-related infections that has been reported increasingly in recent years through the development of diagnostic methods. The aim of this report was to present two Dengue fever cases originating from travel. There was a story of mosquito bite during a trip to Sri Lanka travel in our first case. The patient was 30 years old and maculopapular rash appeared on the fifth day of contact. Three days after the onset of the rash, she has admitted to our clinic, complaining with fever and chills. Increased leukopenia and muscle enzymes were detected in the laboratory analysis. Real-time reverse transcriptase polimerase chain reaction (RT-PCR) was positive in the serum sample. The patient was followed up with supportive care and discharged by improvement. The second case, a 24-year-old male, had a story of mosquito bite during his trip to Malaysia. After the patient complained of fever, chills, fever, nausea, vomiting and muscle pain, the Dengue virus (DENV) NS1 antigen test performed in this country was found to be positive. In the second case, there was no maculopapular rash and laboratory analysis showed an increase in leukopenia, thrombocytopenia and muscle enzymes. RT-PCR positivity was detected in the serum sample. The patient was followed up with supportive treatment and discharged with cure. DENV infections are caused by DENV which is common in the tropical areas of the world. There are four DENV-1, DENV-2, DENV-3 and DENV-4 serotypes. DENV infections can present different clinical manifestations such as asymptomatic disease, viral syndrome, Dengue haemorrhagic fever, and Dengue shock syndrome. Dengue fever is often accompanied by arthritis, maculopapular rash and high fever. Our cases were defined as Dengue fever according to this definition. In the diagnosis of the disease, it is necessary first to be suspicious of the disease and the travel history must be questioned. In the definitive diagnosis, virus isolation, antigen, nucleic acid detection and serological tests are used. The virus can be isolated from blood, serum, urine and tissues. In the first five days after beginning of the symptoms associated with DENV infections, serum RT-PCR and Dengue NS1 antigen test may be positive.


  • Use of Rifabutin as an Alternative Agent for Human Brucellosis: A Case Report

    by Oguz Karabay, Huseyin Dogus Okan, Adem Simsek, Ertugrul Guclu

    Drugs that have a good intracellular passage are used in the treatment of brucellosis. According to our knowledge, there is no report in English about rifabutin usage in brucellosis. We present a case that developed intolerance to many anti-brucella drugs, who was then successfully treated with a combination of rifabutin, ofloxacin, and ceftriaxone.